Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn

Index by author

November 01, 1985; Volume 13,Issue 6
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

B

  1. Billing, B

    1. You have access
      Comparison of theophylline and theobromine metabolism in man.
      D J Birkett, R Dahlqvist, J O Miners, A Lelo and B Billing
      Drug Metabolism and Disposition November 1985, 13 (6) 725-728;
  2. Birkett, D J

    1. You have access
      Comparison of theophylline and theobromine metabolism in man.
      D J Birkett, R Dahlqvist, J O Miners, A Lelo and B Billing
      Drug Metabolism and Disposition November 1985, 13 (6) 725-728;
  3. Bowman, E R

    1. You have access
      In vivo mammalian metabolism of methylamine and methylurea and their metabolic interrelationship.
      M S Dar and E R Bowman
      Drug Metabolism and Disposition November 1985, 13 (6) 682-689;
  4. Breeze, R G

    1. You have access
      Structure of the glutathione adduct of activated 3-methylindole indicates that an imine methide is the electrophilic intermediate.
      M R Nocerini, G S Yost, J R Carlson, D J Liberato and R G Breeze
      Drug Metabolism and Disposition November 1985, 13 (6) 690-694;
  5. Butler, E G

    1. You have access
      Paraoxon hydrolysis vs. covalent binding in the elimination of paraoxon in the rabbit.
      E G Butler, H W Eckerson and B N La Du
      Drug Metabolism and Disposition November 1985, 13 (6) 640-645;

C

  1. Campbell, P

    1. You have access
      In vitro digitoxin metabolism. Rate-limiting step and alteration following spironolactone pretreatment.
      W C Kershaw, P Campbell and G L Lage
      Drug Metabolism and Disposition November 1985, 13 (6) 635-639;
  2. Carlson, J R

    1. You have access
      Structure of the glutathione adduct of activated 3-methylindole indicates that an imine methide is the electrophilic intermediate.
      M R Nocerini, G S Yost, J R Carlson, D J Liberato and R G Breeze
      Drug Metabolism and Disposition November 1985, 13 (6) 690-694;
  3. Chism, J P

    1. You have access
      Isomer- and sex-specific bioactivation of mononitrotoluenes. Role of enterohepatic circulation.
      J P Chism and D E Rickert
      Drug Metabolism and Disposition November 1985, 13 (6) 651-657;
  4. Coffman, B L

    1. You have access
      Separation, purification, and characterization of digitoxigenin-monodigitoxoside UDP-glucuronosyltransferase activity.
      L von Meyerinck, B L Coffman, M D Green, R B Kirkpatrick, A Schmoldt and T R Tephly
      Drug Metabolism and Disposition November 1985, 13 (6) 700-704;
  5. Cossum, P A

    1. You have access
      Metabolism of dinitrobenzenes by rat isolated hepatocytes.
      P A Cossum and D E Rickert
      Drug Metabolism and Disposition November 1985, 13 (6) 664-668;
  6. Crooks, P A

    1. You have access
      In vitro characteristics of guinea pig lung aromatic azaheterocycle N-methyltransferase.
      K C Cundy and P A Crooks
      Drug Metabolism and Disposition November 1985, 13 (6) 658-663;
  7. Cundy, K C

    1. You have access
      In vitro characteristics of guinea pig lung aromatic azaheterocycle N-methyltransferase.
      K C Cundy and P A Crooks
      Drug Metabolism and Disposition November 1985, 13 (6) 658-663;

D

  1. Dahlqvist, R

    1. You have access
      Comparison of theophylline and theobromine metabolism in man.
      D J Birkett, R Dahlqvist, J O Miners, A Lelo and B Billing
      Drug Metabolism and Disposition November 1985, 13 (6) 725-728;
  2. Dar, M S

    1. You have access
      In vivo mammalian metabolism of methylamine and methylurea and their metabolic interrelationship.
      M S Dar and E R Bowman
      Drug Metabolism and Disposition November 1985, 13 (6) 682-689;
  3. Durham, S

    1. You have access
      Effects of taurocholate infusion on biliary excretion in isolated perfused rat livers. Decreased biliary excretion of dibromosulfophthalein in pregnancy.
      S Durham, R Mack and M Vore
      Drug Metabolism and Disposition November 1985, 13 (6) 695-699;

E

  1. Eckerson, H W

    1. You have access
      Paraoxon hydrolysis vs. covalent binding in the elimination of paraoxon in the rabbit.
      E G Butler, H W Eckerson and B N La Du
      Drug Metabolism and Disposition November 1985, 13 (6) 640-645;

G

  1. Gill, S S

    1. You have access
      Age-related changes in the activities of epoxide hydrolases in different tissues of mice.
      S Kaur and S S Gill
      Drug Metabolism and Disposition November 1985, 13 (6) 711-715;
  2. Green, M D

    1. You have access
      Separation, purification, and characterization of digitoxigenin-monodigitoxoside UDP-glucuronosyltransferase activity.
      L von Meyerinck, B L Coffman, M D Green, R B Kirkpatrick, A Schmoldt and T R Tephly
      Drug Metabolism and Disposition November 1985, 13 (6) 700-704;

H

  1. Hazelton, G A

    1. You have access
      Furosemide 1-O-acyl glucuronide. In vitro biosynthesis and pH-dependent isomerization to beta-glucuronidase-resistant forms.
      A Rachmel, G A Hazelton, A L Yergey and D J Liberato
      Drug Metabolism and Disposition November 1985, 13 (6) 705-710;
  2. Hill, D L

    1. You have access
      Pharmacokinetic and metabolism studies of two novel 1-deaza-7,8-dihydropteridines in mice.
      P E Noker, D L Hill, J R Kalin, C G Temple and J A Montgomery
      Drug Metabolism and Disposition November 1985, 13 (6) 677-681;
  3. Houston, J B

    1. You have access
      Quantitation of extrahepatic metabolism. Pulmonary and intestinal conjugation of naphthol.
      M Mistry and J B Houston
      Drug Metabolism and Disposition November 1985, 13 (6) 740-745;

I

  1. Inaba, T

    1. You have access
      Mephenytoin hydroxylase activity in human liver: inhibition by steroids.
      M Jurima, T Inaba and W Kalow
      Drug Metabolism and Disposition November 1985, 13 (6) 746-749;

J

  1. Jurima, M

    1. You have access
      Mephenytoin hydroxylase activity in human liver: inhibition by steroids.
      M Jurima, T Inaba and W Kalow
      Drug Metabolism and Disposition November 1985, 13 (6) 746-749;

K

  1. Kalin, J R

    1. You have access
      Pharmacokinetic and metabolism studies of two novel 1-deaza-7,8-dihydropteridines in mice.
      P E Noker, D L Hill, J R Kalin, C G Temple and J A Montgomery
      Drug Metabolism and Disposition November 1985, 13 (6) 677-681;
  2. Kalow, W

    1. You have access
      Mephenytoin hydroxylase activity in human liver: inhibition by steroids.
      M Jurima, T Inaba and W Kalow
      Drug Metabolism and Disposition November 1985, 13 (6) 746-749;
  3. Kannan, R

    1. You have access
      Tissue uptake and metabolism of amiodarone after chronic administration in rabbits.
      R Kannan, S Miller and B N Singh
      Drug Metabolism and Disposition November 1985, 13 (6) 646-650;
  4. Kaur, S

    1. You have access
      Age-related changes in the activities of epoxide hydrolases in different tissues of mice.
      S Kaur and S S Gill
      Drug Metabolism and Disposition November 1985, 13 (6) 711-715;
  5. Keith, R A

    1. You have access
      S-Methylation of D- and L-penicillamine by human erythrocyte membrane thiol methyltransferase.
      R A Keith, D M Otterness, A L Kerremans and R M Weinshilboum
      Drug Metabolism and Disposition November 1985, 13 (6) 669-676;
  6. Kerremans, A L

    1. You have access
      S-Methylation of D- and L-penicillamine by human erythrocyte membrane thiol methyltransferase.
      R A Keith, D M Otterness, A L Kerremans and R M Weinshilboum
      Drug Metabolism and Disposition November 1985, 13 (6) 669-676;
  7. Kershaw, W C

    1. You have access
      In vitro digitoxin metabolism. Rate-limiting step and alteration following spironolactone pretreatment.
      W C Kershaw, P Campbell and G L Lage
      Drug Metabolism and Disposition November 1985, 13 (6) 635-639;
  8. Kirkpatrick, R B

    1. You have access
      Separation, purification, and characterization of digitoxigenin-monodigitoxoside UDP-glucuronosyltransferase activity.
      L von Meyerinck, B L Coffman, M D Green, R B Kirkpatrick, A Schmoldt and T R Tephly
      Drug Metabolism and Disposition November 1985, 13 (6) 700-704;

L

  1. La Du, B N

    1. You have access
      Paraoxon hydrolysis vs. covalent binding in the elimination of paraoxon in the rabbit.
      E G Butler, H W Eckerson and B N La Du
      Drug Metabolism and Disposition November 1985, 13 (6) 640-645;
  2. Lage, G L

    1. You have access
      In vitro digitoxin metabolism. Rate-limiting step and alteration following spironolactone pretreatment.
      W C Kershaw, P Campbell and G L Lage
      Drug Metabolism and Disposition November 1985, 13 (6) 635-639;
  3. Lelo, A

    1. You have access
      Comparison of theophylline and theobromine metabolism in man.
      D J Birkett, R Dahlqvist, J O Miners, A Lelo and B Billing
      Drug Metabolism and Disposition November 1985, 13 (6) 725-728;
  4. Liberato, D J

    1. You have access
      Structure of the glutathione adduct of activated 3-methylindole indicates that an imine methide is the electrophilic intermediate.
      M R Nocerini, G S Yost, J R Carlson, D J Liberato and R G Breeze
      Drug Metabolism and Disposition November 1985, 13 (6) 690-694;
    2. You have access
      Furosemide 1-O-acyl glucuronide. In vitro biosynthesis and pH-dependent isomerization to beta-glucuronidase-resistant forms.
      A Rachmel, G A Hazelton, A L Yergey and D J Liberato
      Drug Metabolism and Disposition November 1985, 13 (6) 705-710;

M

  1. Mack, R

    1. You have access
      Effects of taurocholate infusion on biliary excretion in isolated perfused rat livers. Decreased biliary excretion of dibromosulfophthalein in pregnancy.
      S Durham, R Mack and M Vore
      Drug Metabolism and Disposition November 1985, 13 (6) 695-699;
  2. Miller, S

    1. You have access
      Tissue uptake and metabolism of amiodarone after chronic administration in rabbits.
      R Kannan, S Miller and B N Singh
      Drug Metabolism and Disposition November 1985, 13 (6) 646-650;
  3. Minami, H

    1. You have access
      Physiologically based pharmacokinetic model for cefazolin in rabbits and its preliminary extrapolation to man.
      A Tsuji, K Nishide, H Minami, E Nakashima, T Terasaki and T Yamana
      Drug Metabolism and Disposition November 1985, 13 (6) 729-739;
  4. Miners, J O

    1. You have access
      Comparison of theophylline and theobromine metabolism in man.
      D J Birkett, R Dahlqvist, J O Miners, A Lelo and B Billing
      Drug Metabolism and Disposition November 1985, 13 (6) 725-728;
  5. Mishima, M

    1. You have access
      Metabolism of strychnine in vitro.
      M Mishima, Y Tanimoto, Z Oguri and H Yoshimura
      Drug Metabolism and Disposition November 1985, 13 (6) 716-721;
  6. Mistry, M

    1. You have access
      Quantitation of extrahepatic metabolism. Pulmonary and intestinal conjugation of naphthol.
      M Mistry and J B Houston
      Drug Metabolism and Disposition November 1985, 13 (6) 740-745;
  7. Montgomery, J A

    1. You have access
      Pharmacokinetic and metabolism studies of two novel 1-deaza-7,8-dihydropteridines in mice.
      P E Noker, D L Hill, J R Kalin, C G Temple and J A Montgomery
      Drug Metabolism and Disposition November 1985, 13 (6) 677-681;

N

  1. Nakashima, E

    1. You have access
      Physiologically based pharmacokinetic model for cefazolin in rabbits and its preliminary extrapolation to man.
      A Tsuji, K Nishide, H Minami, E Nakashima, T Terasaki and T Yamana
      Drug Metabolism and Disposition November 1985, 13 (6) 729-739;
  2. Nishide, K

    1. You have access
      Physiologically based pharmacokinetic model for cefazolin in rabbits and its preliminary extrapolation to man.
      A Tsuji, K Nishide, H Minami, E Nakashima, T Terasaki and T Yamana
      Drug Metabolism and Disposition November 1985, 13 (6) 729-739;
  3. Nocerini, M R

    1. You have access
      Structure of the glutathione adduct of activated 3-methylindole indicates that an imine methide is the electrophilic intermediate.
      M R Nocerini, G S Yost, J R Carlson, D J Liberato and R G Breeze
      Drug Metabolism and Disposition November 1985, 13 (6) 690-694;
  4. Noker, P E

    1. You have access
      Pharmacokinetic and metabolism studies of two novel 1-deaza-7,8-dihydropteridines in mice.
      P E Noker, D L Hill, J R Kalin, C G Temple and J A Montgomery
      Drug Metabolism and Disposition November 1985, 13 (6) 677-681;

O

  1. Oguri, Z

    1. You have access
      Metabolism of strychnine in vitro.
      M Mishima, Y Tanimoto, Z Oguri and H Yoshimura
      Drug Metabolism and Disposition November 1985, 13 (6) 716-721;
  2. Otterness, D M

    1. You have access
      S-Methylation of D- and L-penicillamine by human erythrocyte membrane thiol methyltransferase.
      R A Keith, D M Otterness, A L Kerremans and R M Weinshilboum
      Drug Metabolism and Disposition November 1985, 13 (6) 669-676;

R

  1. Rachmel, A

    1. You have access
      Furosemide 1-O-acyl glucuronide. In vitro biosynthesis and pH-dependent isomerization to beta-glucuronidase-resistant forms.
      A Rachmel, G A Hazelton, A L Yergey and D J Liberato
      Drug Metabolism and Disposition November 1985, 13 (6) 705-710;
  2. Rickert, D E

    1. You have access
      Isomer- and sex-specific bioactivation of mononitrotoluenes. Role of enterohepatic circulation.
      J P Chism and D E Rickert
      Drug Metabolism and Disposition November 1985, 13 (6) 651-657;
    2. You have access
      Metabolism of dinitrobenzenes by rat isolated hepatocytes.
      P A Cossum and D E Rickert
      Drug Metabolism and Disposition November 1985, 13 (6) 664-668;

S

  1. Schmoldt, A

    1. You have access
      Separation, purification, and characterization of digitoxigenin-monodigitoxoside UDP-glucuronosyltransferase activity.
      L von Meyerinck, B L Coffman, M D Green, R B Kirkpatrick, A Schmoldt and T R Tephly
      Drug Metabolism and Disposition November 1985, 13 (6) 700-704;
  2. Singh, B N

    1. You have access
      Tissue uptake and metabolism of amiodarone after chronic administration in rabbits.
      R Kannan, S Miller and B N Singh
      Drug Metabolism and Disposition November 1985, 13 (6) 646-650;
  3. Soulinna, E M

    1. You have access
      7-Ethoxycoumarin O-deethylation and methylumbelliferone conjugation in isolated fetal and adult bovine hepatocytes.
      E M Soulinna and A M Winberg
      Drug Metabolism and Disposition November 1985, 13 (6) 722-724;

T

  1. Tanimoto, Y

    1. You have access
      Metabolism of strychnine in vitro.
      M Mishima, Y Tanimoto, Z Oguri and H Yoshimura
      Drug Metabolism and Disposition November 1985, 13 (6) 716-721;
  2. Temple, C G

    1. You have access
      Pharmacokinetic and metabolism studies of two novel 1-deaza-7,8-dihydropteridines in mice.
      P E Noker, D L Hill, J R Kalin, C G Temple and J A Montgomery
      Drug Metabolism and Disposition November 1985, 13 (6) 677-681;
  3. Tephly, T R

    1. You have access
      Separation, purification, and characterization of digitoxigenin-monodigitoxoside UDP-glucuronosyltransferase activity.
      L von Meyerinck, B L Coffman, M D Green, R B Kirkpatrick, A Schmoldt and T R Tephly
      Drug Metabolism and Disposition November 1985, 13 (6) 700-704;
  4. Terasaki, T

    1. You have access
      Physiologically based pharmacokinetic model for cefazolin in rabbits and its preliminary extrapolation to man.
      A Tsuji, K Nishide, H Minami, E Nakashima, T Terasaki and T Yamana
      Drug Metabolism and Disposition November 1985, 13 (6) 729-739;
  5. Tsuji, A

    1. You have access
      Physiologically based pharmacokinetic model for cefazolin in rabbits and its preliminary extrapolation to man.
      A Tsuji, K Nishide, H Minami, E Nakashima, T Terasaki and T Yamana
      Drug Metabolism and Disposition November 1985, 13 (6) 729-739;

V

  1. von Meyerinck, L

    1. You have access
      Separation, purification, and characterization of digitoxigenin-monodigitoxoside UDP-glucuronosyltransferase activity.
      L von Meyerinck, B L Coffman, M D Green, R B Kirkpatrick, A Schmoldt and T R Tephly
      Drug Metabolism and Disposition November 1985, 13 (6) 700-704;
  2. Vore, M

    1. You have access
      Effects of taurocholate infusion on biliary excretion in isolated perfused rat livers. Decreased biliary excretion of dibromosulfophthalein in pregnancy.
      S Durham, R Mack and M Vore
      Drug Metabolism and Disposition November 1985, 13 (6) 695-699;

W

  1. Weinshilboum, R M

    1. You have access
      S-Methylation of D- and L-penicillamine by human erythrocyte membrane thiol methyltransferase.
      R A Keith, D M Otterness, A L Kerremans and R M Weinshilboum
      Drug Metabolism and Disposition November 1985, 13 (6) 669-676;
  2. Winberg, A M

    1. You have access
      7-Ethoxycoumarin O-deethylation and methylumbelliferone conjugation in isolated fetal and adult bovine hepatocytes.
      E M Soulinna and A M Winberg
      Drug Metabolism and Disposition November 1985, 13 (6) 722-724;

Y

  1. Yamana, T

    1. You have access
      Physiologically based pharmacokinetic model for cefazolin in rabbits and its preliminary extrapolation to man.
      A Tsuji, K Nishide, H Minami, E Nakashima, T Terasaki and T Yamana
      Drug Metabolism and Disposition November 1985, 13 (6) 729-739;
  2. Yergey, A L

    1. You have access
      Furosemide 1-O-acyl glucuronide. In vitro biosynthesis and pH-dependent isomerization to beta-glucuronidase-resistant forms.
      A Rachmel, G A Hazelton, A L Yergey and D J Liberato
      Drug Metabolism and Disposition November 1985, 13 (6) 705-710;
  3. Yoshimura, H

    1. You have access
      Metabolism of strychnine in vitro.
      M Mishima, Y Tanimoto, Z Oguri and H Yoshimura
      Drug Metabolism and Disposition November 1985, 13 (6) 716-721;
  4. Yost, G S

    1. You have access
      Structure of the glutathione adduct of activated 3-methylindole indicates that an imine methide is the electrophilic intermediate.
      M R Nocerini, G S Yost, J R Carlson, D J Liberato and R G Breeze
      Drug Metabolism and Disposition November 1985, 13 (6) 690-694;
Back to top
PreviousNext

In this issue

Drug Metabolism and Disposition
Vol. 13, Issue 6
1 Nov 1985
  • Table of Contents
  • Index by author
  • Back Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • Cytochrome P450 inhibitors. Evaluation of specificities in the in vitrometabolism of therapeutic agents by human liver microsomes.
  • Prediction of Human Clearance of Twenty-Nine Drugs from Hepatic Microsomal Intrinsic Clearance Data: An Examination of In Vitro Half-Life Approach and Nonspecific Binding to Microsomes
  • DRUG-DRUG INTERACTIONS FOR UDP-GLUCURONOSYLTRANSFERASE SUBSTRATES: A PHARMACOKINETIC EXPLANATION FOR TYPICALLY OBSERVED LOW EXPOSURE (AUCI/AUC) RATIOS
  • In Vitro-In Vivo Scaling of CYP Kinetic Data Not Consistent with the Classical Michaelis-Menten Model
  • THE HUMAN INTESTINAL CYTOCHROME P450 “PIE”
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics